等待开盘 08-12 09:30:00 美东时间
-0.020
-0.10%
今日重点评级关注:花旗:维持Apellis Pharmaceuticals"买入"评级,目标价从41美元升至46美元;杰富瑞:维持Kiniksa Pharmaceuticals"买入"评级,目标价从45美元升至54美元
07-30 09:36
Across the recent three months, 4 analysts have shared their insights on Alerus...
07-30 03:01
U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on ...
07-28 22:29
Alerus Financial press release (NASDAQ:ALRS): Q2 Non-GAAP EPS of $0.72 beats by $0.17. Revenue of $74.8M (+45.6% Y/Y) beats by $4.82M. More on Alerus Financial Alerus Financial Corporation 2025 Q1 - R...
07-28 19:08
Alerus Finl (NASDAQ:ALRS) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.55 by 31.39 percent. This is a 111.76 percent increase over earnings of $0.34 per share from the
07-28 19:05
Companies Reporting Before The Bell • Bank of Hawaii (NYSE:BOH) is likely to re...
07-28 16:32
## 输出 Roland Kolbeck, Ph.D. has been appointed as Chief Scientific Officer of Aclaris Therapeutics, succeeding Joe Monahan, Ph.D., who will remain as Special Scientific Advisor through March 2026. Dr. Kolbeck brings extensive experience in inflammation and antibody development, supporting the company's pipeline of immuno-inflammatory product candidates. Dr. Monahan will continue to contribute during his phased retirement, having built a renowned...
07-28 12:45
Alerus Finl (NASDAQ:ALRS) will release its quarterly earnings report on Monday,...
07-26 02:02
Companies Reporting Before The Bell • Guardforce AI Co (NASDAQ:GFAI) is project...
04-28 16:32